Oramed Pharmaceuticals Inc (ORMP) — Defensive Interval Ratio
Oramed Pharmaceuticals Inc (ORMP) has a Defensive Interval Ratio of 1819 days as of March 2026. Defensive assets of $52.64 Million (cash $-, short-term investments $52.64 Million, receivables $-) cover 1819 days of daily cash needs of $28.94K/day. See Oramed Pharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Oramed Pharmaceuticals Inc Defensive Interval Ratio (2008–2025)
This chart shows how Oramed Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 1819 days, meaning defensive assets of $52.64 Million can fund 1819 days of operations without new revenue. See Oramed Pharmaceuticals Inc (ORMP) net asset quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Oramed Pharmaceuticals Inc (2008–2025)
The table below presents the year-by-year Defensive Interval Ratio for Oramed Pharmaceuticals Inc from 2008 to 2025, covering 18 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Oramed Pharmaceuticals Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1618 days | $84.58 Million | $52.29K/day | $- | $79.95 Million | ▼ -4001 days |
| 2024 | 5618 days | $87.51 Million | $15.58K/day | $- | $87.51 Million | ▲ +4569 days |
| 2023 | 1049 days | $152.99 Million | $145.79K/day | $- | $152.99 Million | ▼ -6272 days |
| 2022 | 7321 days | $115.26 Million | $15.74K/day | $- | $115.26 Million | ▲ +6398 days |
| 2021 | 923 days | $16.89 Million | $18.30K/day | $- | $16.89 Million | ▼ -735 days |
| 2020 | 1658 days | $20.60 Million | $12.43K/day | $- | $20.60 Million | ▼ -333 days |
| 2019 | 1991 days | $28.95 Million | $14.54K/day | $- | $28.95 Million | ▼ -51 days |
| 2018 | 2042 days | $25.47 Million | $12.47K/day | $- | $25.47 Million | ▲ +900 days |
| 2017 | 1141 days | $16.15 Million | $14.15K/day | $- | $16.15 Million | ▼ -1591 days |
| 2016 | 2733 days | $27.11 Million | $9.92K/day | $- | $27.11 Million | ▼ -703 days |
| 2015 | 3436 days | $14.02 Million | $4.08K/day | $- | $14.02 Million | ▼ -4043 days |
| 2014 | 7479 days | $19.94 Million | $2.67K/day | $- | $19.53 Million | ▲ +2888 days |
| 2013 | 4591 days | $6.27 Million | $1.36K/day | $- | $6.20 Million | ▲ +4427 days |
| 2012 | 163 days | $288.41K | $1.77K/day | $- | $200.31K | ▼ -624 days |
| 2011 | 787 days | $951.65K | $1.21K/day | $- | $384.56K | ▲ +651 days |
| 2010 | 137 days | $171.61K | $1.26K/day | $- | $100.00K | ▼ -1287 days |
| 2009 | 1423 days | $1.44 Million | $1.01K/day | $- | $1.00 Million | ▲ +334 days |
| 2008 | 1089 days | $2.73 Million | $2.50K/day | $- | $2.73 Million | — |